BiomX To Present at H.C. Wainwright 1st Annual Investor Conference on Bacteriophage

Rhea-AI Summary

BiomX Inc. (NYSE American: PHGE) announced that CEO Jonathan Solomon will present at the H.C. Wainwright 1st Annual Investor Conference on Bacteriophage on November 30, 2022. The virtual presentation is scheduled for 10:30 AM EST.

BiomX is innovating in the microbiome sector with novel phage therapies targeting specific pathogenic bacteria. The presentation will be available via the Company’s website.

NESS ZIONA, Israel, Nov. 29, 2022 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer of BiomX, will present at the H.C. Wainwright 1^st Annual Investor Conference on Bacteriophage on November 30, 2022.

H.C Wainwright 1st Annual Investor Conference on Bacteriophage
Date & Time:	Wednesday, November 30, 10:30 AM EST (Virtual Presentation)
Presenter:	Jonathan Solomon
Conference registration:	Link

The presentation will also be accessible through the Investors section of the Company’s website at https://ir.biomx.com/news-events/ir-calendar.

About BiomX Inc.

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit www.biomx.com

BiomX Contacts

Investor Relations:
LifeSci Advisors, LLC
John Mullaly
(617)-698-9253
jmullaly@lifesciadvisors.com

BiomX, Inc.
Anat Primovich
Corporate Project Manager
+972 (50) 697-7228
anatp@biomx.com

FAQ

When will BiomX present at the H.C. Wainwright conference?

BiomX will present on November 30, 2022, at 10:30 AM EST.

What is the focus of BiomX's presentation at the conference?

The presentation will focus on BiomX's novel phage therapies targeting pathogenic bacteria.

How can I access BiomX's presentation?

BiomX's presentation will be accessible through the Investors section of their website.

What is BiomX's stock symbol?

BiomX's stock symbol is PHGE.